Literature DB >> 11304796

Immunohistochemical demonstration of alpha1,4-N-acetylglucosaminyltransferase that forms GlcNAcalpha1,4Galbeta residues in human gastrointestinal mucosa.

M X Zhang1, J Nakayama, E Hidaka, S Kubota, J Yan, H Ota, M Fukuda.   

Abstract

alpha1,4-N-acetylglucosaminyltransferase (alpha4GnT) is a glycosyltransferase that mediates transfer of GlcNAc to betaGal residues with alpha1,4-linkage, forming GlcNAcalpha1--> 4Galbeta-->R structures. In normal human tissues, glycoproteins having GlcNAcalpha1-->4Galbeta-->R structures at non-reducing terminals are exclusively limited to the mucins secreted from glandular mucous cells of gastric mucosa, Brunner's gland of duodenum, and accessory gland of pancreaticobiliary tract. Recently, we have isolated a cDNA encoding human alpha4GnT by expression cloning. Although alpha4GnT plays a key role in producing this unique glycan in vitro, the actual localization of alpha4GnT was not determined. In this study we examined the localization of alpha4GnT in various human tissues, including gastrointestinal mucosa, using a newly developed antibody against human alpha4GnT. The specificity of the antibody was confirmed by analyses of human gastric adenocarcinoma AGS cells transfected by alpha4GnT cDNA. Expression of alpha4GnT was largely associated with the Golgi region of mucous cells that produce the mucous glycoproteins having GlcNAcalpha1-->4Galbeta-->R, such as the glandular mucous cells of stomach and Brunner's gland. An immunoprecipitation experiment disclosed that two distinct mucin proteins, MUC5AC and MUC6 present in gastric mucin, carried the GlcNAcalpha1-->4Galbeta-->R structures. These results indicate that alpha4GnT is critical to form the mucous glycoproteins having GlcNAcalpha1-->4Galbeta-->R on MUC6 and MUC5AC in vivo.(J Histochem Cytochem 49:587-596, 2001)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304796     DOI: 10.1177/002215540104900505

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  18 in total

1.  Essential role of gastric gland mucin in preventing gastric cancer in mice.

Authors:  Fumitoshi Karasawa; Akira Shiota; Yukinobu Goso; Motohiro Kobayashi; Yoshiko Sato; Junya Masumoto; Maiko Fujiwara; Shuichi Yokosawa; Takashi Muraki; Shinichi Miyagawa; Masatsugu Ueda; Michiko N Fukuda; Minoru Fukuda; Kazuhiko Ishihara; Jun Nakayama
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

Review 2.  Reduced αGlcNAc glycosylation on gastric gland mucin is a biomarker of malignant potential for gastric cancer, Barrett's adenocarcinoma, and pancreatic cancer.

Authors:  Kazuhiro Yamanoi; Jun Nakayama
Journal:  Histochem Cell Biol       Date:  2018-04-16       Impact factor: 4.304

3.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2018-05-18       Impact factor: 4.304

4.  Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.

Authors:  Kazuhiro Yamanoi; Keiko Ishii; Michihiko Tsukamoto; Shiho Asaka; Jun Nakayama
Journal:  Virchows Arch       Date:  2018-05-29       Impact factor: 4.064

5.  Automated motif discovery from glycan array data.

Authors:  Sharath R Cholleti; Sanjay Agravat; Tim Morris; Joel H Saltz; Xuezheng Song; Richard D Cummings; David F Smith
Journal:  OMICS       Date:  2012-08-09

6.  Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.

Authors:  Shiho Asaka; Tomoyuki Nakajima; Masanobu Momose; Tsutomu Miyamoto; Takeshi Uehara; Hiroyoshi Ota
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

7.  MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung.

Authors:  Kazuhiro Yamanoi; Chifumi Fujii; Hanae Yuzuriha; Mai Kumazawa; Masayuki Shimoda; Katsura Emoto; Hisao Asamura; Jun Nakayama
Journal:  Histochem Cell Biol       Date:  2022-03-30       Impact factor: 4.304

8.  Alpha1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth.

Authors:  Heeseob Lee; Ping Wang; Hitomi Hoshino; Yuki Ito; Motohiro Kobayashi; Jun Nakayama; Peter H Seeberger; Minoru Fukuda
Journal:  Glycobiology       Date:  2008-05-05       Impact factor: 4.313

9.  Genetic variation in a4GnT in relation to Helicobacter pylori serology and gastric cancer risk.

Authors:  Zongli Zheng; Yanbin Jia; Lifang Hou; Christina Persson; Meredith Yeager; Jolanta Lissowska; Stephen J Chanock; Martin Blaser; Wong-Ho Chow; Weimin Ye
Journal:  Helicobacter       Date:  2009-10       Impact factor: 5.753

10.  Carbohydrate recognition by an architecturally complex α-N-acetylglucosaminidase from Clostridium perfringens.

Authors:  Elizabeth Ficko-Blean; Christopher P Stuart; Michael D Suits; Melissa Cid; Matthew Tessier; Robert J Woods; Alisdair B Boraston
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.